Exploring optimal sequencing of radiation and immunotherapy combinations.

Adv Radiat Oncol · 2018 · PMC6200887 · PMID 30370348

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an important trendno p-value reported

47 Although not directly assessing the difference between radiation and immune-therapy sequencing, there was an important trend of improved responses for patients who received anti-PD-L1 mAb closer to the chemoradiation administration.

also in 1,052 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.